Levaquin, an antibiotic, used to treat bacterial infections has been linked to a number of studies suggesting the prescription drug's side effects may be severe. One of the alleged side effects includes tendon rupture, that some have said may cause permanent damgage or require surgery to repair.
The U.S. Food and Drug Administration (FDA) recently approved an antibiotic known as Levaquin (levofloxacin), part of the fluoroquinolone antibiotic group of drugs used to fight infections, for use by children even though the drug's potential link to severe side effects remains uncertain.
Potential Serious Levaquin Side Effects
Levaquin, from makers Ortho-McNeil, was released to the market in 2004. The drug is used to treat a wide range of bacterial infections including pneumonia, bronchitis, skin infections, urinary tract and prostate infections, Chlamydia and gonorrhea.
The FDA has also approved Levaquin for use against anthrax inhalation for both adults and, recently, children as well. However, several studies have been published recently the antibiotic to severe and spontaneous Achilles tendon rupture among patients treated with Levaquin.
Studies of Levaquin Risks
The Journal of Antimicrobial Chemotherapy published a study conducted by the Department of Microbiology at The University Hospital Lewisham, of several patients being treated with Levaquin, although all were elderly in age, the report found that the link to "Achilles tendonitis and rupture may be more common adverse effects of levofloxacin than previously thought."
Despite the fact that this risk has surfaced among adult patients, the FDA continued to approve the drug for use in children under the age or 18. Some researchers believe that the use of the drug for children should be further studied prior to approval, but the FDA has done nothing to block or slow the drug's availability on the market. Another study reflecting the same sentiment involving risks of tendonitis was published in The Journal of the American Board of Family Medicine. Here medical researchers noted that there has been a rise in tendon rupture incidence since the 1980s when the first cases of the effects of fluoroquinolones on tendons were documented.
The study concluded that as more individuals are prescribed levofloxacin, the risk of tendon rupture would continue to rise as well.
Individuals who received the drug as far back as six months or more are also at risk for the tendon rupture and those with muscle and joint swelling should contact a medical professional immediately.
The study noted that the risks of tendonitis are severe among patients of levofloxacins and the outcome can range from minor discomfort to death. The only way to reduce the morbidity rate of patients associated with the drug-induced tendonitis or rupture is with prevention of prescribing the drug or intervention of patients taking the drug. Child Risks of Levaquin Consumption
While most of the previous studies were conducted on elderly patients, the Mayo Clinic released an article on the potential risks of prescribing Levaquin to patients younger than 18 years of age. According to the article, published in mid-2007, the use of levofloxacins for children can potentially disrupt bone development.
Young animals, for which the drug was tested on, had developmental issues because of the antibiotic. The Mayo Clinic expressed caution when prescribing the drug to young individuals and extreme care must be taken to ensure the proper dosage is prescribed and consumed.
Additional Risks of Levaquin Side Effects
In addition to the risk of tendon rupture among patients, Levaquin may cause other discomforting side effects including sensitivity to sunlight, which is caused through levofloxacin mixing improperly with other medications like antacids containing aluminum, calcium or magnesium; sensitivity in the abdomen or cramping in the stomach; blisters; diarrhea; confusion; agitation; fever; trembling; sensation of the skin burning; and psychosis and hallucinations.
The Mayo Clinic recommends immediate medical attention if any of the above side effects occur in patients.
Individuals who also have preexisting medical conditions are also advised to avoid the medication because of serious complications that can occur. Patients with diabetes may find that Levaquin causes uncontrollable levels of blood sugar levels, or those with spinal conditions may find a higher instance of seizures.
Also, the effects of kidney disease are increased among patients with kidney-related issues because of the slow removal of levofloxacin from the body, according to the Mayo Clinic.
What To Do if Levaquin Tendon Rupture Occurs
Patients who have taken Levaquin and suffer from tendon rupture or who have signs of tendon swelling or pain should seek medical attention immediately, as the severity of the incidence may increase if medical assistance is not sought.
Michael Rudzinski from the VA Medical Center in New York explained that a wheelchair, cane or crutches may be required to aid in curing tendon rupture. However, if the condition is severe, surgery may be required to repair torn tendons. Those with Levaquin-induced tendonitis are also advised to contact an experienced Levaquin attorney who can offer assistance with developing a Levaquin lawsuit. To learn more about becoming involved with a Levaquin lawsuit by contacting an experienced pharmaceutical attorney.
Medical Journal Finds NSAIDs Offer More Harm Than Good to Heart Failure Patients
Recently, a medical journal discovered more harmful side effects among patients consuming nonsteroidal anti-inflammatory drugs (NSAIDs) than helpful side effects among heart failure patients.
Peanut Butter Recall Sickens Hundreds, Criminal Investigation Underway
The recent peanut butter recall has resulted in nearly 600 illnesses and at least eight fatalities, prompting a criminal investigation by government officials. Despite ongoing recalls, the contaminated peanut butter continues to pose a significant health risk to many Americans.
Researchers Study Toxicity Levels of Mesothelioma Treatments
Researchers are attempting to increase the validity of mesothelioma treatments among patients suffering from the fatal condition by testing the highest dosage levels that can be administered to patients without resulting in toxicity levels among individuals.
